发明公开
- 专利标题： COMPOUNDS AND THERAPEUTICAL USE THEREOF
- 专利标题（中）： 化合物及其治疗用途
-
申请号： EP06717281.7申请日： 2006-01-03
-
公开(公告)号： EP1833482A2公开(公告)日： 2007-09-19
- 发明人: CAI, Sui Xiong , ANDERSON, Mark B. , WILLARDSEN, Adam , SIRISOMA, Nilantha Sudath , ZHANG, Hong , SUZUKI, Kazuyuki
- 申请人： MYRIAD GENETICS, INC. , Cytovia, Inc.
- 申请人地址： 320 Wakara Way Salt Lake City, Utah 84108 US
- 专利权人： MYRIAD GENETICS, INC.,Cytovia, Inc.
- 当前专利权人： MYRIAD GENETICS, INC.,Cytovia, Inc.
- 当前专利权人地址： 320 Wakara Way Salt Lake City, Utah 84108 US
- 代理机构： Adam, Holger
- 优先权： US641260P 20050103
- 国际公布： WO2006074147 20060713
- 主分类号： A61K31/50
- IPC分类号： A61K31/50 ; A61K31/519 ; A61K31/517 ; C07D239/72 ; C07D239/00 ; C07D241/04 ; C07D265/12 ; C07D321/00 ; C07D401/00 ; C07D403/00 ; C07D498/00
摘要：
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
信息查询
